Neuropsychiatric symptoms during 24 hours after dobutamine-atropine stress testing: a prospective study in 1,006 patients.

Background: The aim of this study was to investigate the incidence and predictors of neuropsychiatric (NP) symptoms during 24 hours after dobutamine-atropine stress testing (DST).

Methods: Consecutive outpatients undergoing DST were asked to return a questionnaire regarding symptoms during the following 24 hours. Trained registered nurses administered the Delirium Observation Screening Scale before and after DST.